U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07502781) titled 'Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants' on March 16.
Brief Summary: Anemia is a condition in which there are not enough red blood cells to carry oxygen throughout the body. It is very common in extremely preterm infants (born before 28 weeks of pregnancy), and many of these babies require red blood cell transfusions during their hospital stay.
Currently, transfusions are given using red blood cells donated by adults. An alternative option is to use red blood cells collected from umbilical cord blood, which may be more similar to a newborn's own blood. This approach has been used ...